Company Data
Clearside Biomedical Inc.
Ticker
CLSD
Current Price
$1.03 -1.9%
Market Cap
$78.1M
Price Target
Refer to Report
Volume
467.1K
52wk Range
$0.801 - $2.12
Overview
Clearside Biomedical Inc is a United States based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.